Okyo Pharma

Okyo Pharma is a company listed under the stock ticker OKYO (GB).

View the org chart displaying its 8 main executives

Most searched biographies at Okyo Pharma

• Gary Jacob, Chief Executive Officer and Director
• Bernard Denoyer, Non-Executive Director
• Willy Simon, Non-Executive Director

Create your alert
to follow the executive moves at Okyo Pharma.

Okyo Pharma has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).
• AbbVie has acquired Landos Biopharma (posted on May 25 2024).
• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Okyo Pharma

• Media - Okyo Pharma
• Press Releases - Okyo Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• View more press releases Close

Social media about Okyo Pharma

• Okyo Pharma on Wikipedia, Google News & Yahoo Finance
• Okyo Pharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Gary Jacob

Call Okyo Pharma at +44 207...

View the org chart

Register to receive your alert

Report an error